UCAL LIMITED has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
UCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
UCAL Limited submitted its unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) following a board meeting on August 13, 2025. On a standalone basis, revenue from operations rose to ₹13,960.10 lakhs (from ₹12,786.78 lakhs a year ago, about 9% growth), but profit after tax fell to ₹32.41 lakhs (from ₹45.32 lakhs), translating to EPS of ₹0.15. On a consolidated basis, revenue grew modestly to ₹19,452.27 lakhs, but the company slipped into a wider loss of ₹600.99 lakhs (vs ₹251.33 lakhs loss a year ago), with EPS at negative ₹2.72. The US subsidiary UCAL Holdings Inc. alone posted a loss of ₹547.66 lakhs for the quarter, dragging group profitability. Auditors R. Subramanian & Co LLP flagged an Emphasis of Matter regarding pending RBI approval for writing off trade receivables (~₹2,854 lakhs) and loans (~₹12,338 lakhs) owed by UCAL Holdings Inc., USA, originally written off in FY18.
Standalone results are marginally positive but consolidated losses have widened sharply, driven by the loss-making US subsidiary. The unresolved RBI approval for the ~₹15,192 lakh write-off from the US arm remains a key overhang, and shareholders should watch for any reversal risk or further provisioning related to this exposure.